The family of products includes cancellous or cortical particulate, a moldable collagen block and a cancellous particulate pre-loaded into a delivery syringe to assist with optimal placement. It is designed for extraction sockets, grafting for implant placement, ridge augmentation and sinus augmentation.
BioHorizons is a majority-owned subsidiary of Henry Schein.
More articles on oral care:
San Antonio ADA meeting to have $21M economic impact
5 dentists in the news
13 dentists on the move
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
